Godavari Drugs Limited share price
BSE: GODAVARI
Key numbers
- Market cap
- ₹ 137 Cr
- Current price
- ₹ 125.18
- 52-week high / low
- ₹ 135 / 70
- Stock P/E
- 32.8
- Book value
- ₹ 100.4
- Dividend yield
- 0.00%
- ROCE
- 6.5%
- ROE
- 6.9%
- Debt to equity
- 1.08
- Sales growth (3 yrs)
- -12.8%
- Profit growth (3 yrs)
- 2.6%
- 1-year return
- 46.5%
About Godavari Drugs Limited
Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin hydrochloride (HCL), ciprofloxacin lactate, ciprofloxacin betaine, carbamazepine, enrofloxacin, mefenamic acid, ambroxol hydrochloride, piracetam, as well as 2,5-dihydroxy-1,4- dithiane. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was incorporated in 1987 and is based in Secunderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 24 | 27 | 22 | 33 | 28 |
| Operating profit | 3 | 2 | 2 | 3 | 3 |
| Net profit | 1 | 1 | 1 | 1 | 1 |
| EPS (₹) | 1.38 | 1.33 | 1.01 | 1.71 | 1.10 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.